BF Biosciences Share Price, PSX Chart & Forecast (PSX: BFBIO) BF Biosciences Limited
Rs123.47
Up +1.31 (+1.07%) on the day
As of close · Source: PSX · End-of-day data, not a live feed
BFBIO key statistics
Session of 29 Oct 2026 · Select ? beside a label for a plain-English definition
- OpenOpenThe price of the first trade in the session. Glossary
- Rs 122.10
- HighHighThe highest price traded during the period — today's session unless stated otherwise. Glossary
- Rs 124.75
- LowLowThe lowest price traded during the period — today's session unless stated otherwise. Glossary
- Rs 121.00
- Prev closeCloseThe official last price of the session. The day's change is measured from the previous close, and it is the reference for the next session. Glossary
- Rs 122.16
- VolumeVolumeThe number of shares traded in the session. A move on heavy volume carries more conviction than the same move on a quiet day. Glossary
- 206,635
- TurnoverTurnoverThe rupee value of shares traded (volume × price). Pakistani market reports often use "turnover" loosely for the number of shares traded, so check the unit. Glossary
- Rs 25.5M
- Market capMarket capitalisationShare price multiplied by the number of shares outstanding — what the market says the whole company is worth. Use it, not the share price, to compare the size of two businesses. Glossary
- Rs 10.91B
- P/E ratioP/E ratioShare price divided by earnings per share — how many rupees you pay for one rupee of annual profit. Compare it only with companies in the same sector. Glossary
- 16.6
- EPSEPS (earnings per share)Net profit divided by shares outstanding — the company's earnings attributable to one share. Rising EPS over several years is the cleanest evidence a business is growing. Glossary
- Rs 7.16
- Dividend yieldDividend yieldAnnual dividend per share divided by the share price, as a percentage. A very high yield is often a warning: the price may have fallen sharply, and the dividend may be cut next. Glossary
- —
- BetaBetaHow much a stock tends to move relative to the market. A beta of 1 moves with it, above 1 amplifies it, below 1 dampens it — it measures co-movement, not quality. Glossary
- 0.97
- ROEROE (return on equity)Net profit as a percentage of shareholders' equity — how efficiently management turns the owners' capital into profit. Consistently high ROE without heavy debt is a sign of a durable business. Glossary
- —
- Book value / shareBook valueAssets minus liabilities — the company's accounting net worth, usually quoted per share. Glossary
- —
- P/B ratioP/B (price-to-book)Share price divided by book value per share. Below 1 means the market values the company at less than its stated net assets — a reason to investigate, not an automatic bargain. Glossary
- —
- 52-week range52-week rangeThe lowest and highest price over the past year. It shows where today's price sits, but a stock near its 52-week low is not automatically cheap. Glossary
-
119.97123.47172.23
— means not available. For BFBIO that is dividend yield, as no cash dividend from the past twelve months is on file; ROE, book value and P/B, which need audited accounts we do not hold yet. We leave a figure blank rather than estimate it.
BFBIO at a glance
What the figures on this page say, in plain English
Strengths
Nothing in the data on this page reads as a clear strength today.
Cautions
Downtrend. Trades below its 20-day (Rs 124.83) and 50-day (Rs 126.85) moving averages.
Near its 52-week low. Trades 2.9% above its 52-week low of Rs 119.97.
Model reads bearish. The automated model reads BFBIO as bearish at 67% confidence.
What this means: each line restates a figure for BFBIO shown on this page and is recomputed after every session. It describes the data; it is not a recommendation to buy or sell.
Model outlook
rule-engine-v2Strongly bearishAI signalThe model's directional reading of the stock over the next ten sessions, on a five-step scale from strongly bearish to strongly bullish, built from price and indicator history. A description of the data, not investment advice. Glossary
67% confidenceConfidenceHow strongly the model leans toward its call. It is not the probability of being right — the graded record against the base rate is the figure for that. Glossary · Short Term
The model reads BFBIO as strongly bearish — an overall score of 28/100 from the rule-based fallback, which is a blend of inputs, not a probability. See the graded record and what drove it ↓
Automated model output, not a recommendation. A reading is a statistical lean; weigh it against the live record in the model card.
BFBIO price chart
Daily BFBIO prices with 20- and 50-day averages and Bollinger Bands. Drag to zoom; hover for each day's figures.
28 Oct 2025 – 29 Oct 2026: ▼ −19.68% · high Rs 172.23 · low Rs 119.97
BFBIO share price and analysis
BF Biosciences Limited (BFBIO) last traded at Rs 123.47 on the Pakistan Stock Exchange, where it rose 1.07% on the session of 29 October 2026. Volume was 206,635 shares, a turnover of Rs 25.5 million. Over the past year the share has traded between Rs 119.97 and Rs 172.23, putting the current price close to its 12-month low.
The price sits below both its 20-day (124.83) and 50-day (126.85) moving averages, which is the configuration usually read as a downtrend. The 14-day RSI is 44.4, a neutral reading. ADX at 18.2 indicates a weak or rangebound trend.
The company is capitalised at roughly Rs 10.9 billion and is classified under Pharmaceuticals. It trades on a price-to-earnings ratio of 16.6, meaning the market is paying about Rs 16.6 for every rupee of annual earnings. Earnings per share stand at Rs 7.16. A beta of 0.97 against the KSE-100 means the share has moved roughly in line with the wider market over the past year.
BFBIO ranks 13th of 34 Pharmaceuticals companies by market value. Its price-to-earnings ratio of 16.6 compares with the Pharmaceuticals median of 16.6, putting it broadly in line with its sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.
Our forecasting model currently reads BFBIO as strongly bearish over a short term horizon, at 67% confidence. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.
This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.
Other Pharmaceuticals stocks
BFBIO is a Pharmaceuticals listing. Compare it against the rest of the sector, or read what actually drives Pharmaceuticals companies on the PSX.
-
ABOTAbbott Laboratories (Pakistan) Limited971.75▲ +1.15% -
GLAXOGlaxoSmithKline Pakistan Limited326.01▲ +3.50% -
GOCGOC (Pak) Limited.234.17▼ −0.23% -
DIILDiamond Industries Limited84.86▲ +9.72% -
OTSUOtsuka Pakistan Limited400.91▲ +0.68%
Learn how to read this page
- How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
- Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
- How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.
BFBIO technical indicators — RSI, MACD & moving averages
Momentum and trend gauges for BFBIO after the session of 29 Oct 2026, each with a one-line reading of what the number means.
RSI (14)
RSI (Relative Strength Index)A momentum gauge from 0 to 100, usually over 14 days. Above 70 is called overbought and below 30 oversold, but in a strong trend RSI can stay there for weeks — it is not a buy or sell instruction. GlossaryBFBIO reads 44.4 — neutral (between 30 and 70). Above 70 is conventionally read as overbought, below 30 as oversold; dashed lines mark both.
MACD (12, 26, 9)
MACDThe 12-day exponential moving average minus the 26-day, with a 9-day signal line on top. A cross above the signal line means short-term momentum has turned up; it lags, and misfires in sideways markets. GlossaryBFBIO reads -0.938 — below its signal line: momentum fading. Bars show the gap between MACD and its signal line.
- RSI (14)
- 44.4
- Neutral (between 30 and 70)
- Stochastic %K
- 27.8
- Neutral (between 20 and 80)
- ADX (14)ADX (Average Directional Index)Measures trend strength from 0 to 100 without saying which direction. Below about 20 the market is ranging; above 25 a real trend is present. Glossary
- 18.2
- Weak or sideways trend (below 25)
- Williams %R
- -72.2
- Neutral (between −80 and −20)
- SMA 20SMA 20The average closing price of the last 20 sessions, redrawn each day — a short-term trend line. Moving averages describe what has happened; they do not predict. Glossary
- 124.83
- Price is 1.1% below it
- SMA 50SMA 50The average closing price of the last 50 sessions — the most watched medium-term trend line. Price above a rising 50-day average is a common definition of an uptrend. Glossary
- 126.85
- Price is 2.7% below it
- MACD
- -0.938
- Below its signal line: momentum fading
- ATR (14)
- 1.414
- A typical day moves about 1.1% of the price
- Bollinger upperBollinger BandsA moving average with bands two standard deviations above and below; they widen as volatility rises. Touching the upper band means the price is stretched, not that it must reverse. Glossary
- 128.89
- Price is 4.2% below it
- Bollinger lower
- 120.77
- Price is 2.2% above it
- Momentum (10)
- -6.43
- Lower than 10 sessions ago
- Technical score
- 16
- Weak, on a 0–100 scale
BFBIO fundamentals & valuation ratios
Set beside the median Pharmaceuticals company
| Measure | BFBIO | Sector median |
|---|---|---|
| Market cap | Rs 10.91B | No. 13 of 34 by size |
| P/E ratio | 16.6 | 16.6 |
| EPS | Rs 7.16 | — |
| P/B ratio | — | — |
| Dividend yield | — | — |
| ROE | — | — |
| Beta | 0.97 | — |
| Volatility (annualised) | 52.2% | — |
Fundamental score
42/100
What this means: BFBIO scores 42 on a 0–100 check built only from the figures we hold for it — P/E and volatility. 50 is neutral; compare it within a sector, not across sectors. A dash in the table is a figure we do not hold for BFBIO; it adds nothing to the score rather than being guessed.
BFBIO price history — last 30 sessions
Daily open, high, low and close, newest first
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Thu, 29 Oct 2026 | 122.10 | 124.75 | 121.00 | 123.47 | ▲ +1.07% | 206,635 |
| Wed, 28 Oct 2026 | 123.20 | 123.20 | 122.16 | 122.16 | ▼ −0.84% | 43,078 |
| Tue, 27 Oct 2026 | 123.00 | 123.20 | 123.00 | 123.20 | ▲ +0.16% | 14,914 |
| Mon, 26 Oct 2026 | 122.73 | 123.00 | 122.73 | 123.00 | ▲ +0.22% | 35,001 |
| Fri, 23 Oct 2026 | 124.50 | 124.50 | 122.73 | 122.73 | ▼ −1.42% | 26,298 |
| Thu, 22 Oct 2026 | 126.51 | 126.51 | 124.50 | 124.50 | ▼ −1.59% | 33,123 |
| Wed, 21 Oct 2026 | 125.61 | 126.51 | 125.61 | 126.51 | ▲ +0.72% | 15,770 |
| Tue, 20 Oct 2026 | 126.07 | 126.07 | 125.61 | 125.61 | ▼ −0.36% | 31,713 |
| Mon, 19 Oct 2026 | 128.65 | 128.65 | 126.07 | 126.07 | ▼ −2.01% | 69,244 |
| Fri, 16 Oct 2026 | 129.90 | 129.90 | 128.65 | 128.65 | ▼ −0.96% | 168,772 |
| Thu, 15 Oct 2026 | 126.77 | 129.90 | 126.77 | 129.90 | ▲ +2.47% | 2,524,664 |
| Wed, 14 Oct 2026 | 126.06 | 126.77 | 126.06 | 126.77 | ▲ +0.56% | 78,613 |
| Tue, 13 Oct 2026 | 125.96 | 126.06 | 125.96 | 126.06 | ▲ +0.08% | 303,505 |
| Mon, 12 Oct 2026 | 124.18 | 125.96 | 124.18 | 125.96 | ▲ +1.43% | 75,240 |
| Fri, 9 Oct 2026 | 123.15 | 124.18 | 123.15 | 124.18 | ▲ +0.84% | 87,526 |
| Thu, 8 Oct 2026 | 123.99 | 123.99 | 123.15 | 123.15 | ▼ −0.68% | 43,482 |
| Wed, 7 Oct 2026 | 123.60 | 123.99 | 123.60 | 123.99 | ▲ +0.32% | 21,931 |
| Tue, 6 Oct 2026 | 122.45 | 123.60 | 122.45 | 123.60 | ▲ +0.94% | 15,369 |
| Mon, 5 Oct 2026 | 124.68 | 124.68 | 122.45 | 122.45 | ▼ −1.79% | 27,252 |
| Fri, 2 Oct 2026 | 126.34 | 126.34 | 124.68 | 124.68 | ▼ −1.31% | 45,827 |
| Thu, 1 Oct 2026 | 128.40 | 128.40 | 126.34 | 126.34 | ▼ −1.60% | 48,187 |
| Wed, 30 Sep 2026 | 127.22 | 128.40 | 127.22 | 128.40 | ▲ +0.93% | 70,888 |
| Tue, 29 Sep 2026 | 127.51 | 127.51 | 127.22 | 127.22 | ▼ −0.23% | 106,612 |
| Mon, 28 Sep 2026 | 126.89 | 127.51 | 126.89 | 127.51 | ▲ +0.49% | 20,077 |
| Fri, 25 Sep 2026 | 125.73 | 126.89 | 125.73 | 126.89 | ▲ +0.92% | 15,025 |
| Thu, 24 Sep 2026 | 127.92 | 127.92 | 125.73 | 125.73 | ▼ −1.71% | 35,019 |
| Wed, 23 Sep 2026 | 125.43 | 127.92 | 125.43 | 127.92 | ▲ +1.99% | 65,776 |
| Tue, 22 Sep 2026 | 124.50 | 125.43 | 124.50 | 125.43 | ▲ +0.75% | 45,452 |
| Mon, 21 Sep 2026 | 124.67 | 124.67 | 124.50 | 124.50 | ▼ −0.14% | 50,634 |
| Fri, 18 Sep 2026 | 123.55 | 124.67 | 123.55 | 124.67 | ▲ +0.91% | 33,392 |
All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.
BFBIO — frequently asked questions
What is BFBIO's share price today?
BF Biosciences Limited (BFBIO) last traded at Rs 123.47 on the Pakistan Stock Exchange, up 1.07% on the session of 29 October 2026. The day's range was Rs 121.00 to Rs 124.75 on 206,635 shares. These are end-of-day figures published by the exchange, not a live trading feed.
What is the 52-week high and low for BFBIO on the PSX?
BFBIO has traded between Rs 119.97 and Rs 172.23 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.
Is BFBIO Shariah-compliant on the PSX?
Yes. The Pakistan Stock Exchange lists BFBIO in its Shariah-screened KMI All Share index, which means the company passed the screening set with Meezan Bank at the last review — the business-activity test plus the financial ratio tests on interest-bearing debt, illiquid assets and non-compliant income. Screening is periodic, so a company can be dropped when a ratio breaks; check the current KMI index membership before relying on it.
Which PSX indices is BFBIO part of?
BFBIO is a constituent of the KSE All Share and KMI All Share. It is not in the KSE-100, the headline PSX benchmark. Index membership is taken from the exchange's own published listing for each session.
Is BFBIO expensive? What are its valuation ratios?
BFBIO trades on a price-to-earnings ratio of 16.6, so the market is paying about Rs 16.6 for each rupee of annual earnings and earnings per share of Rs 7.16. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.
What is the model outlook for BFBIO?
Our model currently reads BFBIO as strongly bearish over a short term horizon, at 67% confidence. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its graded record against the base rate is published on the page, and it is not investment advice.
Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.
About this data
Prices, volumes and indicators for BFBIO are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.
PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.